Kobe, Japan

Koji Machiya

This inventor holds 3 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1993-2000.


% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1993-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Koji Machiya

Introduction

Koji Machiya is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of chemical processes. With a total of 3 patents to his name, Machiya continues to push the boundaries of innovation in his industry.

Latest Patents

Among his latest patents are groundbreaking processes for producing pyridoindole derivatives. Additionally, he has developed an intermediate for the synthesis and production of amino acid derivatives. These innovations reflect his commitment to advancing pharmaceutical science and improving drug development processes.

Career Highlights

Machiya is currently employed at Fujisawa Pharmaceutical Company, Ltd., where he applies his expertise to various projects. His work has been instrumental in enhancing the company's research and development capabilities. His contributions have not only benefited his employer but have also had a broader impact on the pharmaceutical industry.

Collaborations

Throughout his career, Machiya has collaborated with notable colleagues, including Kooji Kagara and Nobutaka Kawai. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Koji Machiya's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations highlight his dedication to advancing science and improving healthcare solutions. His contributions will undoubtedly continue to influence the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…